CANTEX PHARMACEUTICALS OBTAINS EXCLUSIVE WORLDWIDE RIGHTS TO INTELLECTUAL PROPERTY FROM GEORGETOWN UNIVERSITY FOR AZELIRAGON AS A POTENTIAL TREATMENT OF CANCER-RELATED COGNITIVE DECLINE

/PRNewswire/ -- Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other...

Related Keywords

Juanf Rodriguez ,Stepheng Marcus ,Daniel Kontoh Boateng ,Stephen Marcus ,Casey Mcdonald ,Marc Lippman ,Cantex Pharmaceuticals Inc ,Georgetown University ,Breast Cancer Program ,Prnewswire Cantex Pharmaceuticals Inc ,Georgetown Lombardi Comprehensive Cancer Center ,Lombardi Comprehensive Cancer Center At Georgetown University ,Tv Therapeutics Inc ,Nasdaq ,Expand Collaboration ,Lombardi Comprehensive Cancer ,Lombardi Comprehensive Cancer Center ,Cantex Pharmaceuticals ,Nc ,